Caprion Pharmaceuticals’ Applied BioMedicine group has entered a research collaboration with Vertex Pharmaceuticals. The collaboration will use Caprion’s CellCarta proteomics platform to support clinical biomarker discovery. Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and preclinical studies conducted by Vertex. “Caprion is looking forward to working with Vertex on this clinical biomarker discovery collaboration,” said ...